Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDOI Cancer Study
NCT04072068Phase 4Completed
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Start
- Jun 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in venous thromboembolism (VTE), sponsored by Gruppo Oncologico Italiano di Ricerca Clinica. Started Jun 2019; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04072068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072068.